SINGAPORE, Jan 21 (Reuters) - Shares of Biosensors International BIOS.SI rose 3.8 percent to S$1.08 at open on Monday after the firm said it has received regulatory approval to sell its BioMatrix heart stents in Europe.
The heart-stent maker, which has been waiting for its CE Mark since April 2005, said in a conference call on Friday that it has finally received the certification.
At 0101 GMT, Biosensors shares were up 4.8 percent to S$1.09 with 4.3 traded. Biosensors shares closed at S$1.04 last Thursday.
The firm, which in November posted a net loss of $3 million for its half year fiscal 2008, expects higher revenue from the heart stents to return it to profitability in fiscal year 2009.
(Reporting by Melanie Lee; Editing by Ovais Subhani)
((email@example.com; +65 6403 5666; Reuters Messaging: firstname.lastname@example.org))
For more stories on this company, please open a news browser and type in BIOS.SI-SG-RTRS Keywords: BIOSENSORS STOCKS/
C Reuters 2008. All rights reserved. Republication or redistribution ofReuters content, including by caching, framing or similar means, is expresslyprohibited without the prior written consent of Reuters. Reuters and the Reuterssphere logo are registered trademarks and trademarks of the Reuters group ofcompanies around the world.nSGC001637.SI